Sentence examples for efficacious therapeutics from inspiring English sources

These findings suggest the potential usefulness of a double-targeted approach for designing efficacious therapeutics for the kinase deficient drug resistant tumors.

Adhering to best practices in behavioral neuroscience will enhance the value of animal models for the multiple goals of understanding biological mechanisms, evaluating consequences of genetic mutations, and discovering efficacious therapeutics.

Sustained progress toward eradication will require both improved understanding of infectious reservoirs and efficient development of novel transmission-blocking interventions, such as rapidly acting and highly efficacious therapeutics and vaccines.

Utilization of these cell lines to study the etiology of MM, effects of chemotherapeutic agents, and development of clinical resistance, will provide us with vital information for the evolution of new and more efficacious therapeutics.

Cacna1a mutant mice have provided insights into the neurobiology of EA2 and into the mechanisms underlying treatments and may, therefore, prove useful for developing novel and more efficacious therapeutics.

In many complex processes, like the workings of tumor cells or the immune system, there are thousands of papers published every year on very specific sub-topics, but it is hard to identify those fundamentally new mechanisms that will lead to truly novel and efficacious therapeutics.

Thus, truly efficacious cancer therapeutics must target already established metastases rather than just inhibit tumor growth or dissemination (Valastyan and Weinberg, 2011).

While some issues remain unresolved regarding the monitoring of circulating miRNA as biomarkers or the efficacy of miRNA delivery, novel trials for noninvasive miRNA-based diagnosis and for highly efficacious "miRNA therapeutics" will be a worthwhile step for clinical applications in the near future.

Biotechnological production of the Stx-material is discussed from the perspective of developing efficacious and safe therapeutics.

The increasing facility of antibody modifications has made it possible to construct diverse and efficacious mAb-based therapeutics.

Overall, our studies suggest that to maintain efficacious levels of therapeutics throughout disease progression adjusting doses of elacridar (or other more potent and selective P-gp/BCRP inhibitors yet to be developed) may be the most valuable solution.